As individuals know, Lenskart IPO GMP was good enough, and gradually, due to not having demand, it went down. Moreover, recent news of purchasing shares of its own company also hit hard on the demand.
As per the sources, the CEO of Lenskart, Peyush Bansal, has bought 4.27 crore shares of Lenskart from investors Kedara Capital, Chiratae Ventures, Alpha Wave, and IDG Ventures between July 18 and July 24, 2025.
The total amount was around ₹221 crore as each share was purchased at ₹52 each. This provides him with around an additional 2.5% stake in the company.
Furthermore, in Lenskart ‘s financial background, there is ₹358 Crores of other income, which was a concern for individuals, as the company did not have enough profit; however, the other income makes the company profitable in the FY 2024-2025.
As a result, this kind of news gradually drives down GMP could be a reason, because in the starting phase of Lenskart IPO, individuals were excited and expecting around 20 to 25% listing gain. IPO duration news was at its peak, so this IPO subscribed around 28X.
On the flip side, other IPO, such as the Orkla India, Studds Accessories, and Tata Capital, have also shown enough GMP with good estimated listing gain, resulting in not being able to provide the expected gain because of market uncertainty.
However, investors should do deep research before applying for an IPO in fact, all those companies are also good, but not enough demand and an uncertain market, and the listing gain was not as per expected.
By checking all the significant information regards IPO would be easy and clear for investors whether to invest or not.
